113 related articles for article (PubMed ID: 21091043)
1. Retinoic acid receptor modulators: a perspective on recent advances and promises.
Alvarez S; Bourguet W; Gronemeyer H; de Lera AR
Expert Opin Ther Pat; 2011 Jan; 21(1):55-63. PubMed ID: 21091043
[TBL] [Abstract][Full Text] [Related]
2. Correlation of retinoid binding affinity to retinoic acid receptor alpha with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells.
Dawson MI; Chao WR; Pine P; Jong L; Hobbs PD; Rudd CK; Quick TC; Niles RM; Zhang XK; Lombardo A
Cancer Res; 1995 Oct; 55(19):4446-51. PubMed ID: 7671258
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for engineering of retinoic acid receptor isotype-selective agonists and antagonists.
Géhin M; Vivat V; Wurtz JM; Losson R; Chambon P; Moras D; Gronemeyer H
Chem Biol; 1999 Aug; 6(8):519-29. PubMed ID: 10421757
[TBL] [Abstract][Full Text] [Related]
4. Retinoid receptors and therapeutic applications of RAR/RXR modulators.
le Maire A; Alvarez S; Shankaranarayanan P; Lera AR; Bourguet W; Gronemeyer H
Curr Top Med Chem; 2012; 12(6):505-27. PubMed ID: 22242853
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic applications for ligands of retinoid receptors.
Thacher SM; Vasudevan J; Chandraratna RA
Curr Pharm Des; 2000 Jan; 6(1):25-58. PubMed ID: 10637371
[TBL] [Abstract][Full Text] [Related]
6. Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells.
Schneider SM; Offterdinger M; Huber H; Grunt TW
Cancer Res; 2000 Oct; 60(19):5479-87. PubMed ID: 11034091
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL
Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993
[TBL] [Abstract][Full Text] [Related]
8. Inverse agonists and antagonists of retinoid receptors.
Bourguet W; de Lera AR; Gronemeyer H
Methods Enzymol; 2010; 485():161-95. PubMed ID: 21050917
[TBL] [Abstract][Full Text] [Related]
9. Design of selective nuclear receptor modulators: RAR and RXR as a case study.
de Lera AR; Bourguet W; Altucci L; Gronemeyer H
Nat Rev Drug Discov; 2007 Oct; 6(10):811-20. PubMed ID: 17906643
[TBL] [Abstract][Full Text] [Related]
10. Modulation of Retinoic Acid Receptor Subtypes by 5- and 8-Substituted (Naphthalen-2-yl)-based Arotinoids.
Álvarez S; Lieb M; Martínez C; Khanwalkar H; Rodríguez-Barrios F; Álvarez R; Gronemeyer H; de Lera AR
ChemMedChem; 2015 Aug; 10(8):1378-91. PubMed ID: 26012882
[TBL] [Abstract][Full Text] [Related]
11. RAR and RXR modulation in cancer and metabolic disease.
Altucci L; Leibowitz MD; Ogilvie KM; de Lera AR; Gronemeyer H
Nat Rev Drug Discov; 2007 Oct; 6(10):793-810. PubMed ID: 17906642
[TBL] [Abstract][Full Text] [Related]
12. H11-H12 loop retinoic acid receptor mutants exhibit distinct trans-activating and trans-repressing activities in the presence of natural or synthetic retinoids.
Lefebvre B; Mouchon A; Formstecher P; Lefebvre P
Biochemistry; 1998 Jun; 37(26):9240-9. PubMed ID: 9649304
[TBL] [Abstract][Full Text] [Related]
13. Recruitment of nuclear receptor corepressor and coactivator to the retinoic acid receptor by retinoid ligands. Influence of DNA-heterodimer interactions.
Klein ES; Wang JW; Khalifa B; Gavigan SA; Chandraratna RA
J Biol Chem; 2000 Jun; 275(25):19401-8. PubMed ID: 10777502
[TBL] [Abstract][Full Text] [Related]
14. Pyrazine arotinoids with inverse agonist activities on the retinoid and rexinoid receptors.
García J; Khanwalkar H; Pereira R; Erb C; Voegel JJ; Collette P; Mauvais P; Bourguet W; Gronemeyer H; de Lera AR
Chembiochem; 2009 May; 10(7):1252-9. PubMed ID: 19343742
[TBL] [Abstract][Full Text] [Related]
15. Regulation of retinoid-induced differentiation in embryonal carcinoma PCC4.aza1R cells: effects of retinoid-receptor selective ligands.
Mills KJ; Vollberg TM; Nervi C; Grippo JF; Dawson MI; Jetten AM
Cell Growth Differ; 1996 Mar; 7(3):327-37. PubMed ID: 8838863
[TBL] [Abstract][Full Text] [Related]
16. Two distinct actions of retinoid-receptor ligands.
Chen JY; Clifford J; Zusi C; Starrett J; Tortolani D; Ostrowski J; Reczek PR; Chambon P; Gronemeyer H
Nature; 1996 Aug; 382(6594):819-22. PubMed ID: 8752277
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel non-retinoid pan inverse agonist of the retinoic acid receptors.
Busby SA; Kumar N; Kuruvilla DS; Istrate MA; Conkright JJ; Wang Y; Kamenecka TM; Cameron MD; Roush WR; Burris TP; Griffin PR
ACS Chem Biol; 2011 Jun; 6(6):618-27. PubMed ID: 21381756
[TBL] [Abstract][Full Text] [Related]
18. Increased retinoic acid responsiveness in lung carcinoma cells that are nonresponsive despite the presence of endogenous retinoic acid receptor (RAR) beta by expression of exogenous retinoid receptors retinoid X receptor alpha, RAR alpha, and RAR gamma.
Wan H; Hong WK; Lotan R
Cancer Res; 2001 Jan; 61(2):556-64. PubMed ID: 11212249
[TBL] [Abstract][Full Text] [Related]
19. The isolation and characterization of purified heterocomplexes of recombinant retinoic acid receptor and retinoid X receptor ligand binding domains.
Tian K; Norris AW; Lin CL; Li E
Biochemistry; 1997 May; 36(19):5669-76. PubMed ID: 9153406
[TBL] [Abstract][Full Text] [Related]
20. Pattern of retinoid-induced teratogenic effects: possible relationship with relative selectivity for nuclear retinoid receptors RAR alpha, RAR beta, and RAR gamma.
Elmazar MM; Reichert U; Shroot B; Nau H
Teratology; 1996 Mar; 53(3):158-67. PubMed ID: 8761883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]